1The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993,329:977-986.
2Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus . JAMA, 2002, 287: 2563 -2569.
3Nathan DM , Lachin J, Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348:2294-2303.
4Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005,353:2643-2653.
5UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 38. BMJ, 1998,317:703-713.
6UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33. Lancet, 1998,352:837-853.
8Bergenstal RM, Gavin JR 3rd, Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes : report of a global consensus conference. Am J Med, 2005 ,118 Suppl 9A :1S-6S.
9Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: aconsensus algorithm for the initiation and adjustment of therapy. Aconsensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2006,29 : 1963-1972.
